Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 406919
Gene Symbol: MIR130A
MIR130A
0.010 Biomarker phenotype BEFREE Furthermore, PHLPP2 was identified as a direct target of miR-130a-3p, and the hepatic exosome-derived miR-130a-3p could improve glucose intolerance via suppressing PHLPP2 to activate AKT-AS160-GLUT4 signaling pathway in adipocytes. 31715176 2020
Entrez Id: 407006
Gene Symbol: MIR221
MIR221
0.010 AlteredExpression phenotype BEFREE Overexpression of miR-221/222 impaired the insulin production and secretion of β-cells and resulted in glucose intolerance in vivo. 31761936 2020
Entrez Id: 10419
Gene Symbol: PRMT5
PRMT5
0.010 AlteredExpression phenotype BEFREE The results show that islet-specific KO of Prmt5 reduced expression of the insulin gene and impaired glucose tolerance and GSIS in vivo. 31539871 2020
Entrez Id: 551
Gene Symbol: AVP
AVP
0.010 Biomarker phenotype BEFREE Association of copeptin with sense of coherence in individuals with varying degrees of glucose intolerance. 31738318 2020
Entrez Id: 23035
Gene Symbol: PHLPP2
PHLPP2
0.010 Biomarker phenotype BEFREE Furthermore, PHLPP2 was identified as a direct target of miR-130a-3p, and the hepatic exosome-derived miR-130a-3p could improve glucose intolerance via suppressing PHLPP2 to activate AKT-AS160-GLUT4 signaling pathway in adipocytes. 31715176 2020
Entrez Id: 7462
Gene Symbol: LAT2
LAT2
0.010 GeneticVariation phenotype BEFREE The objectives of the present study were to compare bone characteristics with QCT and other metabolic factors relevant to bone health in subjects with normal glucose tolerance, impaired glucose tolerance and diabetes and to evaluate the association of various lab factors with bone characteristics qualified by QCT. 31545362 2020
Entrez Id: 1506
Gene Symbol: CTRL
CTRL
0.010 Biomarker phenotype BEFREE The thermal sensory thresholds of the IGT-SFN group were significantly different from those of the CTRL group (p < 0.05), except for the heat pain threshold. 31673971 2020
Entrez Id: 6597
Gene Symbol: SMARCA4
SMARCA4
0.010 AlteredExpression phenotype BEFREE In contrast, removal of both Swi/Snf ATPase subunits, Brg1 and Brm, was necessary to compromise adult islet β-cell activity, which included whole-animal glucose intolerance, hyperglycemia, and impaired insulin secretion. 31201281 2019
Entrez Id: 57721
Gene Symbol: METTL14
METTL14
0.010 Biomarker phenotype BEFREE Acute deletion of Mettl14 in β-cells results in glucose intolerance as a result of a reduction in insulin secretion in β-cells even though β-cell mass is increased, which is related to increased β-cell proliferation. 31369074 2019
Entrez Id: 5618
Gene Symbol: PRLR
PRLR
0.010 AlteredExpression phenotype BEFREE Disruption of the Prlr gene in the pancreas resulted in fewer insulin producing cells, which failed to expand appropriately during pregnancy resulting in reduced blood insulin levels and maternal glucose intolerance. 30798322 2019
Entrez Id: 687
Gene Symbol: KLF9
KLF9
0.010 AlteredExpression phenotype BEFREE Adenovirus-mediated overexpression of KLF9 in the mouse liver markedly increased blood glucose levels and impaired glucose tolerance. 31033478 2019
Entrez Id: 3769
Gene Symbol: KCNJ13
KCNJ13
0.010 GeneticVariation phenotype BEFREE In the present study, we show that deletion of Kcnj13 (ie, the gene encoding Kir7.1) specifically from MC4R neurones produced resistance to melanocortin peptide-induced depolarisation of MC4R paraventricular nucleus neurones in brain slices, resistance to the sustained anorexic effect of exogenously administered melanocortin peptides, late onset obesity, increased linear growth and glucose intolerance. 30561082 2019
Entrez Id: 4026
Gene Symbol: LPP
LPP
0.010 Biomarker phenotype BEFREE LPP females displayed glucose intolerance compared to CP females at GD18 (P < 0.001). 31206692 2019
Entrez Id: 4018
Gene Symbol: LPA
LPA
0.010 AlteredExpression phenotype BEFREE We found that the serum ADMA and C-reactive protein levels were significantly increased in IGT and diabetic patients, whereas the levels of lipoprotein A and adiponectin were decreased, especially in diabetic patients with obesity. 30536533 2019
Entrez Id: 9332
Gene Symbol: CD163
CD163
0.010 Biomarker phenotype BEFREE Soluble CD163 and TWEAK in early pregnancy gestational diabetes and later glucose intolerance. 31071174 2019
Entrez Id: 1634
Gene Symbol: DCN
DCN
0.010 Biomarker phenotype BEFREE Loss of decorin in mice caused impaired glucose tolerance in association with increased feed efficiency and altered gene expression in adipose tissue. 30874564 2019
Entrez Id: 23569
Gene Symbol: PADI4
PADI4
0.010 Biomarker phenotype BEFREE Glucometabolic status was defined based on the results of an oral glucose tolerance test (OGTT) as normal glucose regulation (NGR), impaired fasting glucose (IFG), impaired glucose tolerance (IGT) or type 2 diabetes (T2DM). dsDNA and MPO-DNA were measured in serum, while PAD4 mRNA was measured in circulating leukocytes by RT-PCR. 31615411 2019
Entrez Id: 3488
Gene Symbol: IGFBP5
IGFBP5
0.010 AlteredExpression phenotype BEFREE Finally, proteomic analysis revealed high secretion of insulin-like growth factor-binding protein 5 by TMSCs, and its expression was critical for the protective effects of TMSCs against HFD-induced glucose intolerance and ER-stress response in pancreatic islets. 31018536 2019
Entrez Id: 79006
Gene Symbol: METRN
METRN
0.010 Biomarker phenotype BEFREE Association of low serum Meteorin like (Metrnl) concentrations with worsening of glucose tolerance, impaired endothelial function and atherosclerosis. 30825562 2019
Entrez Id: 10869
Gene Symbol: USP19
USP19
0.010 Biomarker phenotype BEFREE The deubiquitinating enzyme USP19 modulates adipogenesis and potentiates high-fat-diet-induced obesity and glucose intolerance in mice. 30386869 2019
Entrez Id: 353
Gene Symbol: APRT
APRT
0.010 AlteredExpression phenotype BEFREE 5'-AMP administration resulted in an increase in dose-dependent purine metabolites and different levels of glucose intolerance. 31447776 2019
Entrez Id: 5579
Gene Symbol: PRKCB
PRKCB
0.010 Biomarker phenotype BEFREE Here, however, we demonstrated that global, but not liver-specific, deletion of PKCɛ in mice protected against diet-induced glucose intolerance and insulin resistance. 30318338 2019
Entrez Id: 54209
Gene Symbol: TREM2
TREM2
0.010 Biomarker phenotype BEFREE Genetic ablation of Trem2 in mice globally inhibits the downstream molecular LAM program, leading to adipocyte hypertrophy as well as systemic hypercholesterolemia, body fat accumulation, and glucose intolerance. 31257031 2019
Entrez Id: 1984
Gene Symbol: EIF5A
EIF5A
0.010 Biomarker phenotype BEFREE The results of the present study suggest that brusatol improves glucose intolerance in mice fed an HFD, possibly by inhibiting protein biosynthesis and eIF5A hypusination.-Turpaev, K., Krizhanovskii, C., Wang, X., Sargsyan, E., Bergsten, P., Welsh, N. The protein synthesis inhibitor brusatol normalizes high-fat diet-induced glucose intolerance in male C57BL/6 mice: role of translation factor eIF5A hypusination. 30462531 2019
Entrez Id: 9289
Gene Symbol: ADGRG1
ADGRG1
0.010 AlteredExpression phenotype BEFREE Adipose Tissue in Persons With HIV Is Enriched for CD4<sup>+</sup> T Effector Memory and T Effector Memory RA<sup>+</sup> Cells, Which Show Higher CD69 Expression and CD57, CX3CR1, GPR56 Co-expression With Increasing Glucose Intolerance. 30941121 2019